Bokf, Na United Therapeutics Corp Transaction History

Bokf, Na

$6.09 Billion
Q2 2025

A detailed history of Bokf, Na transactions in United Therapeutics Corp stock. As of the latest transaction made, Bokf, Na holds 7,892 shares of UTHR stock, worth $3.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,892

Previous 7,749 1.85%

Holding current value

$3.5 Million

Previous $2.39 Million 5.07%

% of portfolio

0.04%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$276.47 - $328.4 $39,535 - $46,961	143 Added 1.85%	7,892 $2.27 Million
Q1 2025 May 13, 2025	BUY	$304.42 - $380.78 $657,851 - $822,865	2,161 Added 38.67%	7,749 $2.39 Million
Q4 2024 Feb 13, 2025	SELL	$348.66 - $410.0 $7,321 - $8,610	-21 Reduced 0.37%	5,588 $1.97 Million
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $9,020 - $10,542	29 Added 0.52%	5,609 $2.01 Million
Q2 2024 Aug 07, 2024	BUY	$228.26 - $319.04 $1.27 Million - $1.78 Million	5,580 New	5,580 $1.78 Million
Q1 2023 May 11, 2023	SELL	$212.99 - $276.17 $946,740 - $1.23 Million	-4,445 Reduced 99.84%	7 $1,000
Q4 2022 Feb 13, 2023	BUY	$205.95 - $280.43 $21,624 - $29,445	105 Added 2.42%	4,452 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $32,934 - $39,555	162 Added 3.87%	4,347 $910,000
Q2 2022 Aug 11, 2022	SELL	$174.81 - $241.14 $8,390 - $11,574	-48 Reduced 1.13%	4,185 $986,000
Q1 2022 May 13, 2022	BUY	$166.16 - $213.96 $703,355 - $905,692	4,233 New	4,233 $759,000
Q3 2019 Nov 13, 2019	SELL	$74.85 - $85.99 $1.22 Million - $1.4 Million	-16,266 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $237,231 - $376,806	-3,119 Reduced 16.09%	16,266 $1.27 Million
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $1,500 - $1,775	-14 Reduced 0.07%	19,385 $2.28 Million
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $56,986 - $72,346	-562 Reduced 2.82%	19,399 $2.11 Million
Q3 2018 Nov 13, 2018	SELL	$113.81 - $129.46 $26,517 - $30,164	-233 Reduced 1.15%	19,961 $2.55 Million
Q2 2018 Aug 13, 2018	SELL	$101.14 - $118.31 $40,557 - $47,442	-401 Reduced 1.95%	20,194 $2.29 Million
Q1 2018 May 14, 2018	BUY	$107.21 - $151.94 $19,405 - $27,501	181 Added 0.89%	20,595 $2.31 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $29,170 - $37,214	-246 Reduced 1.19%	20,414 $3.02 Million
Q3 2017 Nov 14, 2017	SELL	$114.6 - $136.81 $1.11 Million - $1.32 Million	-9,649 Reduced 31.84%	20,660 $2.42 Million
Q2 2017 Aug 14, 2017	BUY	N/A	30,309	30,309 $3.93 Million

Others Institutions Holding UTHR

# of Institutions

745

Shares Held

44.1M

Call Options Held

340K

Put Options Held

318K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $20.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account